Financials
- Market Capitalization 273.31 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.82
Fiyat/satışlar oranı
43.33
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3404 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.54 USD | -1.67% | -8.76% | -9.23% | +26.43% | 270.68 M USD | ||
| 3411 | MGNX MacroGenics, Inc. - Common Stock | 4.21 USD | -1.86% | -11.18% | +1.45% | +180.67% | 267.60 M USD | ||
| 3419 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.96 USD | -2.00% | -17.30% | +23.27% | +317.02% | 263.74 M USD | ||
| 3431 | TRDA Entrada Therapeutics, Inc. - Common Stock | 6.75 USD | -0.74% | -7.15% | +3.37% | -3.16% | 262.04 M USD |